Ticagrelor Oral Tablet - Pre-Treatment
Sponsors
SFJ Pharmaceuticals, Inc.
Conditions
Healthy
Phase 1
Phase 2
Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects
CompletedNCT03928353
Start: 2019-04-16End: 2019-10-09Updated: 2024-05-01
Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old
CompletedNCT04122170
Start: 2019-09-24End: 2021-09-01Updated: 2024-04-08